Approaching the tumor microenvironment in patients with advanced hepatocellular carcinoma using needle biopsy samples.

Hiroaki Kanzaki,Sadahisa Ogasawara,Keisuke Koroki,Kazufumi Kobayashi,Soichiro Kiyono,Naoya Kanogawa,Masato Nakamura,Tomoko Saito,Takayuki Kondo,Ryo Nakagawa,Eiichiro Suzuki,Shingo Nakamoto,Ryosuke Muroyama,Akinobu Tawada,Tetsuhiro Chiba,Makoto Arai,Jun-ichiro Ikeda,Masayuki Ohtsuka,Naoya Kato

Approaching the tumor microenvironment in patients with advanced hepatocellular carcinoma using needle biopsy samples.

2021

Hiroaki Kanzaki
Sadahisa Ogasawara
Keisuke Koroki
Kazufumi Kobayashi
Soichiro Kiyono
Naoya Kanogawa
Masato Nakamura
Tomoko Saito
Takayuki Kondo
Ryo Nakagawa
Eiichiro Suzuki
Shingo Nakamoto
Ryosuke Muroyama
Akinobu Tawada
Tetsuhiro Chiba
Makoto Arai
Jun-ichiro Ikeda
Masayuki Ohtsuka
Naoya Kato

334Background: Currently, combined immunotherapy of atezolizumab (anti-PD-L1 antibody) plus bevacizumab (a humanized anti-VEGF monoclonal antibody) is the standard first-line treatment in patients ...

Keywords:

Tumor microenvironment
Immunotherapy
Hepatocellular carcinoma
in patient
Cancer research
Monoclonal antibody
Bevacizumab
Antibody
Medicine
Atezolizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations